{"abstract":"Section 2003 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) requires generally that prescriptions for controlled substances covered under a Medicare Part D prescription drug plan or Medicare Advantage Prescription Drug Plan (MA/PD) be transmitted by a health care practitioner electronically in accordance with an electronic prescription drug program, beginning January 1, 2021. Further, section 2003 of the SUPPORT Act provides CMS with the authority to, through rulemaking, enforce and specify appropriate penalties for noncompliance with the requirement for electronic prescribing of controlled substances (EPCS). The SUPPORT Act requires CMS to specify, through rulemaking, circumstances and processes by which it may waive the EPCS requirement. This Request for Information (RFI) seeks input from stakeholders about whether CMS should include exceptions to the EPCS and under what circumstances, and whether CMS should impose penalties for noncompliance with this mandate in its rulemaking, and what those penalties should be.","action":"Request for information.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/08/04/2020-16897.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"423","title":42}],"citation":"85 FR 47151","comment_url":null,"comments_close_on":"2020-10-05","correction_of":null,"corrections":[],"dates":"To be assured consideration, comments must be received at one of the addresses provided in the ADDRESSES section, no later than 5 p.m. on October 5, 2020.","disposition_notes":null,"docket_ids":["CMS-3394-NC"],"dockets":[{"supporting_documents":[],"agency_name":"CMS","documents":[{"comment_count":93,"comment_start_date":"2020-08-04","updated_at":"2023-02-28T22:50:18.840-05:00","comment_url":"https://www.regulations.gov/commenton/CMS-2020-0087-0002","allow_late_comments":null,"id":"CMS-2020-0087-0002","comment_end_date":"2020-10-06","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"CMS-2020-0087","title":"Request for Information; Electronic Prescribing for Controlled Substances (EPCS) (CMS-3394-NC)"}],"document_number":"2020-16897","effective_on":null,"end_page":47157,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/08/04/2020-16897.xml","html_url":"https://www.federalregister.gov/documents/2020/08/04/2020-16897/medicare-program-electronic-prescribing-of-controlled-substances-request-for-information-rfi","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-16897?publication_date=2020-08-04","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-08-04/2020-16897/mods.xml","not_received_for_publication":null,"page_length":7,"page_views":{"count":23201,"last_updated":"2026-11-22 10:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-08-04/pdf/2020-16897.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-16897.pdf?1596140118","publication_date":"2020-08-04","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/08/04/2020-16897.txt","regulation_id_number_info":{"0938-AU25":{"issue":"202104","html_url":"https://www.federalregister.gov/regulations/0938-AU25/electronic-prescribing-for-controlled-substances-cms-3394-","title":"Electronic Prescribing for Controlled Substances (CMS-3394)","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202104&RIN=0938-AU25&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"}},"regulation_id_numbers":["0938-AU25"],"regulations_dot_gov_info":{"supporting_documents":[],"regulatory_plan":{"html_url":"https://www.federalregister.gov/regulations/0938-AU25/electronic-prescribing-for-controlled-substances-cms-3394-","title":"Electronic Prescribing for Controlled Substances (CMS-3394)"},"comments_count":93,"agency_id":"CMS","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=CMS-2020-0087","supporting_documents_count":0,"docket_id":"CMS-2020-0087","document_id":"CMS-2020-0087-0002","regulation_id_number":"0938-AU25","title":"Request for Information; Electronic Prescribing for Controlled Substances (EPCS) (CMS-3394-NC)","checked_regulationsdotgov_at":"2023-03-01T03:50:17Z"},"regulations_dot_gov_url":null,"significant":true,"signing_date":null,"start_page":47151,"subtype":null,"title":"Medicare Program: Electronic Prescribing of Controlled Substances; Request for Information (RFI)","toc_doc":"Electronic Prescribing of Controlled Substances; Request for Information","toc_subject":"Medicare Program:\n","topics":[],"type":"Proposed Rule","volume":85}